Cavallari LH - Search Results

1

Association of Genetic Variants With Warfarin-Associated Bleeding Among Patients of African Descent.

De T, Alarcon C, Hernandez W, Liko I, Cavallari LH, Duarte JD, Perera MA. De T, et al. Among authors: cavallari lh. JAMA. 2018 Oct 23;320(16):1670-1677. doi: 10.1001/jama.2018.14955. JAMA. 2018. PMID: 30357299 Free PMC article.

2

Predictors of unstable anticoagulation in African Americans.

Cavallari LH, Aston JL, Momary KM, Shapiro NL, Patel SR, Nutescu EA. Cavallari LH, et al. J Thromb Thrombolysis. 2009 May;27(4):430-7. doi: 10.1007/s11239-008-0236-8. Epub 2008 Jun 19. J Thromb Thrombolysis. 2009. PMID: 18563532

3

Warfarin pharmacogenomics.

Cavallari LH, Limdi NA. Cavallari LH, et al. Curr Opin Mol Ther. 2009 Jun;11(3):243-51. Curr Opin Mol Ther. 2009. PMID: 19479657 Review.

4

Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population.

Nochowitz B, Shapiro NL, Nutescu EA, Cavallari LH. Nochowitz B, et al. Among authors: cavallari lh. Ann Pharmacother. 2009 Jul;43(7):1165-72. doi: 10.1345/aph.1L707. Epub 2009 Jun 23. Ann Pharmacother. 2009. PMID: 19549747

5

Genetic and clinical predictors of warfarin dose requirements in African Americans.

Cavallari LH, Langaee TY, Momary KM, Shapiro NL, Nutescu EA, Coty WA, Viana MA, Patel SR, Johnson JA. Cavallari LH, et al. Clin Pharmacol Ther. 2010 Apr;87(4):459-64. doi: 10.1038/clpt.2009.223. Epub 2010 Jan 13. Clin Pharmacol Ther. 2010. PMID: 20072124

6

The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans.

Perera MA, Gamazon E, Cavallari LH, Patel SR, Poindexter S, Kittles RA, Nicolae D, Cox NJ. Perera MA, et al. Among authors: cavallari lh. Clin Pharmacol Ther. 2011 Mar;89(3):408-15. doi: 10.1038/clpt.2010.322. Epub 2011 Jan 26. Clin Pharmacol Ther. 2011. PMID: 21270790 Free PMC article.

7

Bleeding incidence with concomitant use of antidepressants and warfarin.

Cochran KA, Cavallari LH, Shapiro NL, Bishop JR. Cochran KA, et al. Among authors: cavallari lh. Ther Drug Monit. 2011 Aug;33(4):433-8. doi: 10.1097/FTD.0b013e318224996e. Ther Drug Monit. 2011. PMID: 21743381 Free PMC article.

8

Association of apolipoprotein E genotype with duration of time to achieve a stable warfarin dose in African-American patients.

Cavallari LH, Butler C, Langaee TY, Wardak N, Patel SR, Viana MA, Shapiro NL, Nutescu EA. Cavallari LH, et al. Pharmacotherapy. 2011 Aug;31(8):785-92. doi: 10.1592/phco.31.8.785. Pharmacotherapy. 2011. PMID: 21923605

9

Role of pharmacogenomics in the management of traditional and novel oral anticoagulants.

Cavallari LH, Shin J, Perera MA. Cavallari LH, et al. Pharmacotherapy. 2011 Dec;31(12):1192-207. doi: 10.1592/phco.31.12.1192. Pharmacotherapy. 2011. PMID: 22122181 Free PMC article. Review.

10

Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans.

Cavallari LH, Perera M, Wadelius M, Deloukas P, Taube G, Patel SR, Aquino-Michaels K, Viana MA, Shapiro NL, Nutescu EA. Cavallari LH, et al. Pharmacogenet Genomics. 2012 Feb;22(2):152-8. doi: 10.1097/FPC.0b013e32834f288f. Pharmacogenet Genomics. 2012. PMID: 22158446 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page